Accessibility Menu
 

Targeted Medical Pharma

(OTC) TRGM

Current Price$0.00
Market Cap$3,000
Since IPO (2012)-100%
5 Year-100%
1 Year+9,900%
1 Month+9,900%

Targeted Medical Pharma Financials at a Glance

Market Cap

$3,000

Revenue (TTM)

$5.26M

Net Income (TTM)

$3.04M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-12.42 (Low)

Price

$0.00

Volume

10,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.02

52-Week Range

$0.00 - $0.02

TRGM News

No articles available.

TRGM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Targeted Medical Pharma

Industry

Pharmaceuticals

Headquarters

Los Angeles, CA 90077, US

TRGM Financials

Key Financial Metrics (TTM)

Gross Margin

60%

Operating Margin

-39%

Net Income Margin

-58%

Return on Equity

0%

Return on Capital

17%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.00K

Shares Outstanding

30.19M

Volume

10.00K

Short Interest

0.00%

Avg. Volume

163.934

Financials (TTM)

Gross Profit

$3.17M

Operating Income

$2.03M

EBITDA

$1.66M

Operating Cash Flow

$1.28M

Capital Expenditure

$3.00

Free Cash Flow

$1.28M

Cash & ST Invst.

$82.64K

Total Debt

$5.29M

Targeted Medical Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2015YOY CHG

Revenue

$1.29M

-9.0%

Gross Profit

$775.83K

+1.4%

Gross Margin

60.20%

N/A

Market Cap

$3.00K

N/A

Market Cap/Employee

$100.00

N/A

Employees

30

N/A

Net Income

$581.47K

+60.8%

EBITDA

$313.31K

+69.2%

Quarterly Fundamentals

Name
Q4 2015YOY CHG

Net Cash

$5.21M

-40.6%

Accounts Receivable

$467.50K

+91.8%

Inventory

$92.19K

-27.5%

Long Term Debt

$670.90K

+448.6%

Short Term Debt

$4.62M

+28.5%

Return on Assets

-1.25%

N/A

Return on Invested Capital

16.57%

N/A

Free Cash Flow

$76.54K

-67.8%

Operating Cash Flow

$76.54K

-67.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SYVCSynovics Pharmaceuticals, Inc.
$0.00+0.00%
NLVVFNew Leaf Ventures Inc
$0.00+0.00%
CMRAComera Life Sciences Holdings, Inc.
$0.00+0.00%
SNNAQSienna Biopharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.12-0.07%

Questions About TRGM

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.